Dose-finding study of KP-607 in patients with onychomycosis (PhaseII)
Phase 2
Completed
- Conditions
- Onychomycosis
- Registration Number
- JPRN-jRCT2080225203
- Lead Sponsor
- KAKEN PHARMACEUTICAL CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 81
Inclusion Criteria
Japanese subjects
The subjects diagnosed with onychomycosis
Presence of 20-50% of the area of the target nail being clinically affected (as determined by the Investigator)
Exclusion Criteria
Patients who have received corticosteroids,immunosuppressants, or antifungals drugs within a certain period of time before screening period
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety<br>efficacy<br>Safety, Efficacy
- Secondary Outcome Measures
Name Time Method pharmacokinetics<br>KP-607 and its metabolites concentrations when applied repeatedly to toenails in patients with onychomycosis